Advertisement

Topics

Physicians' concerns on FDA’s interchangeability guidance

05:10 EDT 30 Jun 2017 | Generics and Biosimilars Initiative

The US Food and Drug Administration (FDA) received 52 comments on its draft guidance on the interchangeability of biosimilars with their reference biologicals.

Original Article: Physicians' concerns on FDA’s interchangeability guidance

NEXT ARTICLE

More From BioPortfolio on "Physicians' concerns on FDA’s interchangeability guidance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...